Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
23.40
-0.06 (-0.26%)
At close: Sep 15, 2025, 4:00 PM EDT
23.31
-0.09 (-0.38%)
After-hours: Sep 15, 2025, 6:32 PM EDT
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.28 billion as of September 15, 2025. Its market cap has increased by 75.60% in one year.
Market Cap
1.28B
Enterprise Value
930.85M
1-Year Change
75.60%
Ranking
Category
Stock Price
$23.40
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.28B, an increase of 59.39%. That is a compound annual growth rate of 7.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.29B | 120.04% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | 2.24B | 142.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |